ABSTRACT
Silicon fascinates with incredibly high theoretical energy density as an anode material and considered as a primary candidate to replace well-established graphite. However, further commercialization is hindered by the abnormal volume changes of Si in every single cycle. Silicon embedded in a buffer matrix using the melt-spinning process is a promising approach; however, its metastable nature significantly reduces the microstructure homogeneity, the quality of the composition, and, therefore, the electrochemical performances. Herein, we developed a new approach to design a high-performance Si-alloy with improved microstructure uniformity and electrochemical properties. Namely, annealing at a certain temperature of the melt-spun amorphous alloy ribbon allowed us to evenly distribute Si nanocrystallites in the microstructure with control of average grain size. As a result, the Si-alloy electrode delivers an initial discharge capacity of 900 mAh g-1 and exhibits a high coulombic efficiency of >99% from the second cycle with a capacity retention of â¼98% after 100 cycles. This study provides powerful insights and evidence for the successful application of the proposed approach for commercial purposes.
ABSTRACT
An increasing number of treatments of metastases rely on diagnostics and imaging these days. The facts that the activity of cathepsin B (CB) is markedly linked to the metastatic process and that CB is found highly expressed in the pericellular regions in this process make CB an attractive target for diagnosing metastases. We have developed a CB-sensitive nanoprobe (CB-CNP) consisting of self-quenched CB-sensitive fluorogenic peptide probes conjugated onto the surface of tumor-targeting glycol chitosan nanoparticles (CNPs). The freshly prepared CB-CNP formed a spherical nanoparticle structure (280 nm in diameter) and the fluorescence intensity of CB-CNP was strongly quenched in physiological condition. However, self-quenched CB-CNP boosted strong fluorescence signals in the presence of CB, not of cathepsin l or cathepsin d, due to the CB-specific cleavage of self-quenched peptide probes. Importantly, the intravenously injected CB-CNP demonstrated the potential to discriminate metastases in vivo in three metastatic mouse models, including 4T1-luc2 liver metastases, RFP-B16F10 lung metastases and HT1080 peritoneal metastases. Indeed, Western blot analysis confirmed that the CB expression of metastases had increased compared to normal organ in these metastatic mouse models. CB-CNPs may be useful for depicting metastases through non-invasive CB molecular imaging.